APOL1 and nonpapillary renal cell carcinoma: Even though APOL1 is thought to be dispensable (67), its risk alleles have been proved to worsen kidney disease via cytotoxic effect on podocytes (68), furthermore, according to our research, APOL1 has a critical role in ccRCC.